2019 Dapsone is an oral drug that is used to treat some forms of cutaneous vasculitis as well as Behcet\’s disease. It is an old drug that is in fact an antibiotic 2025 Cited by 23 2020 Cited by 24 Dapsone is used in hypersensitivity vasculitis not for its antimicrobial activity but for its modulatory effect on neutrophil activity. 2019 2024 We present a case of LCV that resolved after treatment with topical dapsone, highlighting a potential new treatment ofLCV with a markedly better side-effect … 1995 This study looks at different treatments for skin vasculitis, a condition causing inflammation of blood vessels in the skin. We\’re comparing three common … Several studies have revealed that dapsone demonstrated efficacy in treating cutaneous purpura in IgAV, but there are few reports of dapsone … It is suggested that dapsone can have a positive effect in chronic IgA vasculitis when cutaneous manifestations last more than 6 weeks at the dosage of 1–2 … 2026 2020 No side effects were life-threatening. Dapsone may be considered as a therapeutic option for gastrointestinal symptoms refractory to CS in children with IgAV. This case further illustrates the clinical utility of handheld Doppler interrogation in the office setting to assist in diagnosis of vascular malformations. Dapsone. An antibiotic which is sometimes used to control vasculitis limited to the skin (neutrophilic dermatoses). It can cause nausea, dizziness, headache … 2020 Four of the 26 patients (15.4%) reported adverse effects of dapsone including arthralgia (7.7%), rash (7.7%), and dapsone hypersensitivity syndrome (3.8%). Dapsone, up to 200 mg daily. The combination of colchicine and dapsone may be more beneficial than either agent alone. Pentoxifylline, 400 mg … 2019 2019 Dapsone, a synthetic sulfone antimicrobial, has been used to treat cutaneous purpura in IgAV, but few authors have reported its use for refractory … … vasculitis … Excellent therapeutic response to dapsone remains the classic clinicopathologic clue for diagnosis. We present a case of LCV resolving after treatment with topical dapsone. Our patient was a 60-year-old woman with biopsy proven LCV which had been present for …